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Variation on a Theme
CMR as the “One-Stop Shop” for Risk Stratiﬁcation
After Infarction?*
Katherine C. Wu, MD
Baltimore, MarylandPredicting prognosis after acute myocardial infarc-
tion (AMI) remains clinically challenging, partly
due to significant interpatient variability in risk
profiles and what is often individualized therapeutic
management. In addition, the risk of poor out-
comes varies as a function of time from AMI,
particularly in the period spanning initial hospital
presentation to the time of discharge. Systematic
approaches to risk assessment have been advocated,
and a number of clinical risk scores have been
developed that can potentially be applied at the
bedside. These include and are not limited to the
See page 835
Thrombolysis In Myocardial Infarction (TIMI) risk
(1), Global Registry of Acute Coronary Events
(GRACE) (2), and CADILLAC (The Controlled
Abciximab and Device Investigation to Lower Late
Angioplasty Complications) trial (3) scores. The
TIMI and GRACE registries were both developed
from cohorts involving 14,000 to 17,000 patients.
The TIMI risk score was designed to predict
30-day mortality in fibrinolytic-eligible patients on
the basis of initial presenting features. The
GRACE model was developed from a multina-
tional registry of acute coronary syndrome patients
and predicts 6-month and 4-year mortality (4) from
clinical features at hospital discharge. Derived from
a database of 2,000 patients enrolled in multi-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Division of Cardiology, Department of Medicine, Johns
Hopkins Medical Institutions, Baltimore, Maryland. Dr. Wu is supported
by the Donald W. Reynolds Cardiovascular Research Center at Johns
Hopkins University. She has received research grant support from GE
Healthcare Technologies.center primary percutaneous coronary intervention
(PCI) trials for AMI, the CADILLAC score pre-
dicts mortality at both 30 days and 1 year. The
prognostic discriminatory capacity of all 3 scores,
both for development and when tested against a
validation cohort, as measured by the C-statistic,
are reported at 0.78 to 0.83 and 0.75 to 0.79.
In addition to patient clinical characteristics,
there are 2 other major determinants of both short-
and long-term survival after myocardial infarction
(MI). These 2 factors are left ventricular ejection
fraction (LVEF) and the severity and extent of
residual coronary artery stenoses that perfuse viable
myocardium. The LVEF is influenced by both the
amount of necrotic myocardium and the extent of
residual myocardium at risk. Current clinical prac-
tice for post-MI risk stratification includes the
assessment of LV function, generally by echocardi-
ography. In addition, in patients in whom coronary
catheterization is not performed, provocable myo-
cardial ischemia is determined by post-MI stress
testing with nuclear or echocardiographic tech-
niques. Direct assessment of infarct size via imaging
techniques is typically not routinely assessed, in part
because it has not been definitively shown to pro-
vide additional prognostic and therapeutic informa-
tion, except in small cardiac nuclear scintigraphic
and cardiac magnetic resonance (CMR) studies.
Furthermore, there is limited clinical emphasis
placed on other potentially important factors such
as adequacy of tissue level reperfusion (microvascu-
lar status) and regional wall motion abnormalities,
both of which might provide independent but not
definitively proven prognostic information.
The potential for CMR to provide a “one-stop
shop” for the assessment of ischemic heart disease
has long been proposed (5,6). CMR is uniquely able
to integrate, in a single examination, the accurate
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Editorial Comment
844ssessment of LV structure, global and regional
ystolic function, together with myocardial infarct
izing, adequacy of tissue level reperfusion (micro-
ascular status), and myocardial ischemic burden/
xtent of viability with low-dose dobutamine. In the
urrent issue of iJACC, Bodi et al. (7) aimed to test
he prognostic value of a comprehensive CMR
ssessment compared with known clinical risk pro-
les. They studied 214 survivors of first ST-
egment elevation MI discharged from a single
enter with median follow-up of approximately 1.5
ears. The majority of patients (58%) received
hrombolytics, but a total of 92% were ultimately
reated with coronary artery stenting during their
ospital stay. CMR was performed at an average
f 7 days after MI, and 4 CMR indexes were
xamined: number of myocardial segments with
) resting wall motion abnormality; 2) wall motion
bnormality with dobutamine; 3) microvascular ob-
truction; and 4) transmural necrosis 50% of the
all. Twenty-one major adverse cardiac events
MACE) were observed. The authors created a
ultivariate model, essentially using stepwise anal-
sis, incorporating a multitude of clinical and CMR
ariables. They concluded that the only variables
hat independently predicted outcome seemed to be
he number of segments with wall motion abnor-
ality and transmural necrosis.
This study highlights the challenges and poten-
ial approach to demonstrating an improvement in
rognostication strategies after MI, particularly
hen expensive, less accessible technologies such as
MR are proposed. Despite limitations with clin-
cal risk scores, they are attractive because they can
e easily applied at the bedside, cost nothing to
erform, and on average can explain a large propor-
ion of post-AMI mortality. It has also been shown
hat there is incremental value when LVEF is added
o clinical prediction scores (3,8). Because LVEF is
eadily obtained clinically by echocardiography, a
pecific challenge for CMR is to demonstrate ad-
itive value of the other unique variables (infarct
ize, infarct transmurality, microvascular obstruc-
ion, resting, and dobutamine-induced wall motion
bnormalities) above and beyond a composite score
f clinical characteristics and LVEF. Simply put,
MR performance should favorably compare with
he discriminant ability of 0.78 of the CADILLAC
core, for instance, which uses only 7 factors: age
65 years, Killip class, baseline LVEF, anemia,
enal insufficiency, triple vessel disease, and post-
rocedural TIMI flow grade. In comparison, from
he Bodi et al. study (7), the C-statistics for infarct vize, transmural necrosis, and number of segments
ith baseline wall motion abnormalities all ex-
eeded 0.75 and might be potentially additive or
ven synergistic to a clinical risk score. Although
his type of approach could be useful, to move
eyond the hypothesis-generation stage of the Bodi
t al. study (7), much larger patient cohorts are
ritical. In the current study, the low total MACE
ates limit the extent to which multiple variables can
e included in any model and thereby preclude any
efinitive conclusions regarding the strengths of the
ndings, particularly with respect to the relative
alues of the individual CMR indexes, as seen by
he wide, overlapping confidence intervals of the
-statistics for each. Also, it will be increasingly
mportant to investigate, with adequate statistical
ower, whether there is differential predictive value
f the CMR indexes on individual, pathophysi-
logically related outcomes rather than composite
nd points (i.e., ischemia and reinfarction compli-
ations should be differentiated from heart failure
dmissions and heart failure deaths vs. arrhythmic
omplications such as sudden cardiac death).
In addition to needing larger cohorts of patients
ith CMR, perhaps collected in the form of a
ulticenter retrospective registry as an initial step,
ttention to the uniformity of the MI patient
opulation studied is warranted, particularly with
espect to other factors that determine outcome.
ne significant independent prognostic variable is
he status of the infarct-related artery (IRA). In the
urrent study, 198 of the 214 total patients were
reated with stenting, either by primary PCI, rescue
CI, or delayed PCI post-thrombolytic therapy; the
tatus of the IRA in the remaining 16 patients is
nclear. Among the thrombolytic therapy group,
9% underwent late revascularization “during rou-
ine catheterization” at a “median of 2 days.” Early
eperfusion with an open epicardial IRA is clearly
eneficial. In contrast, routine late reperfusion
24 h) is no better than medical therapy (9).
lthough the groups with and without MACE
ere matched in terms of initial thrombolytic ther-
py, a more critical question in the thrombolytic
roup was the state of the IRA, ideally at 24 h or at
he time of catheterization pre-intervention (as well
s the time to actual epicardial revascularization).
In conclusion, Bodi et al. (7) provide a novel
pproach to validating a comprehensive CMR
ethod of risk stratification after AMI. The au-
hors certainly raise the bar against which CMR
ust favorably compare, to even be considered a
iable clinical tool. However, the ongoing chal-
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845enges are many, and the current work does not
efinitively answer which of the CMR indexes are
etter than the others or which add incremental
alue to the knowledge of clinical information and
VEF. To do so, there needs to be fair comparisons
ith the multitude of the available risk scores not
nly the TIMI risk that determines short-term
utcome, avoidance of composite end points, inclu-
ion of much larger numbers of patients that allowpercutaneous coronary intervention for cardiac magnetic resrediction models, and adequate control for epicar-
ial reperfusion status. The promise of the CMR
one-stop-shop” survives but remains to be realized
or clinical post-AMI risk stratification.
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